Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP)
- 20 October 1978
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 240 (17), 1896-1897
- https://doi.org/10.1001/jama.240.17.1896
Abstract
Desmopressin acetate is a synthetic vasopressin analog administered by the intranasal route. It is long-acting and well tolerated and may be the agent of choice for treating central diabetes insipidus.This publication has 5 references indexed in Scilit:
- DDAVP (l-Desamino-8-D-arginine-vasopressin) Treatment of Central Diabetes Insipidus—Mechanism of Prolonged Antidiuresis*Journal of Clinical Endocrinology & Metabolism, 1978
- Neurogenic Diabetes Insipidus: Management with dDAVP (1-Desamino-8-D Arginine Vasopressin)Annals of Internal Medicine, 1978
- 1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASEThe Lancet, 1977
- Pathophysiologic and pharmacologic alterations in the release and action of ADHMetabolism, 1976
- DDAVP in the Treatment of Central Diabetes InsipidusNew England Journal of Medicine, 1976